Skip to content 
Blog
Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease. The FDA approved Wainua, which has
December 22, 2023
No Comments
